Literature DB >> 10928110

P53 expression in patients with malignant and benign breast diseases.

A Kalogeraki1, J Panayiotides, D Tamiolakis, M Tzardi, V Chaniotis, G Chalkiadakis, J Melissas, D Stiftsis, P Kanavaros, G S Delides.   

Abstract

Immunohistochemical expression of p53 protein was studied in FNA specimens of 20 breast ductal carcinomas, 20 fibroadenomas and 20 atypical ductal hyperplasia of the breast. Nine cases of breast carcinomas (45%), five fibroadenomas (25%) and four atypical ductal hyperplasia (20%) were found to be p53-immuno-positive. A statistically significant difference was found among p53 staining index of breast carcinomas (mean 72.55%), fibroadenomas (mean 41.2%) and atypical ductal hyperplasia (mean 34%). Variations in p53 expression among individual breast carcinomas was found, and these variations may correlate with prognosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928110

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Gene and protein expression of p53 and p21 in fibroadenomas and adjacent normal mammary tissue.

Authors:  Lolita Schneider; Gisele Branchini; Rodrigo Cericatto; Edison Capp; Ilma Simoni Brum
Journal:  Endocrine       Date:  2008-11-11       Impact factor: 3.633

2.  Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

Authors:  A Elzagheid; T Kuopio; S Pyrhönen; Y Collan
Journal:  Diagn Pathol       Date:  2006-11-08       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.